Achieving Functional Recovery in Schizophrenia: A Patient Case Consult
PROGRAM DESCRIPTION The positive symptoms of schizophrenia, such as hallucinations, delusions, and aggressive symptoms, receive the most clinical attention and are the primary targets for pharmacological treatment. Unfortunately, it is ...
The positive symptoms of schizophrenia, such as hallucinations, delusions, and aggressive symptoms, receive the most clinical attention and are the primary targets for pharmacological treatment. Unfortunately, it is the negative and cognitive symptoms that persist longer than positive symptoms, are more difficult to treat, and contribute to chronicity and disability.1 The newer treatments that have become available are better tolerated with improved side-effect profiles and may have an important role in improving social functioning. There has been an unmet need for better tolerated antipsychotics with broad-based symptom control that improve patient functioning. Recently, FDA-approved agents that offer partial D2 receptor agonism and have other unique properties that may affect the clinical profile offer the possibility of improved symptom management and reduced adverse effects. In this CME Outfitters patient case and expert consult Q&A session, faculty go in-depth with the case study by answering questions while offering evidence, guidelines, and quality measures to improve the long-term management of patients with schizophrenia. ____________________________________________References 1. Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS. Update on schizophrenia and bipolar disorder: focus on cariprazine. Neuropsychiatr Dis Treat. 2016;12:1837-1842.
At the end of this CE activity, participants should be able to:Evaluate the efficacy and safety profiles of recent FDA-approved agents to treat schizophrenia for inclusion into appropriate treatment plansIncorporate into practice the latest advances in the management of schizophrenia
I'm interested in this
Share with others
Write the first review
Share with others